The life science industry has always been steps ahead when it comes to data collection and analysis. It's possible to argue it has been embracing 'Industry 4.0' methodology before the term existed. However, companies have also been aware of the pitfalls of 'big data' for over 40 years.

This three-part webinar series reviews the key considerations for design and conduct of a development plan for a monoclonal antibody (mAb) product.

Autoimmune diseases such as ulcerative colitis require chronic treatment that often causes systemic immunosuppression, increasing long-term cancer and infection risk. Reducing systemic side effects with localized treatment would greatly benefit patients.

5 lessons to master clinical data aggregation, transformation, cleaning and analytics to reduce cost, risk and time

Dry powder inhalers are gaining increasing momentum for drug delivery to the lungs. One of the most used and flexible delivery technologies are capsule-based dry powder inhalers

Bringing a drug from discovery to market is an expensive and time-consuming business. Every drug that fails comes with a cost which could be both reputational and financial. Keeping your development program on track is therefore critical to success.

Join this webinar for a discussion of the most common medical communications business challenges and potential solutions. This event will also feature a live demonstration of how patient-centric medical communications technology can be leveraged to streamline and optimize medical inquiry fulfillment, adverse event reporting and product complaint management.

The science looks promising and vital funding has been secured to take the compound to the clinical stage. What is the best strategy for operationalizing an oncology study in a clinical setting to meet business objectives?

The push to implement risk-based monitoring is continuing across the industry, yet many sponsors are struggling to find the right methods and technology to implement risk-based monitoring, resulting in a time-consuming and expensive effort.

Much of the discussion around patient-centricity today is centered around trial design, which is important and commendable work. Unfortunately, focusing primarily on design overlooks how to instill patient-centric concepts and create a friendly environment in the study once the protocol is finalized.